Wellington Management Group’s Kite Pharma, Inc. KITE Stock Holding History

Wellington Management Group’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-112,933	Closed	-$11.7M	–	2354
2017 Q2	$11.7M	Buy	112,933 +62,497	+124%	+$5.1M	﹤0.01%	1176
2017 Q1	$3.96M	Buy	+50,436	New	+$3.12M	﹤0.01%	1521
2016 Q2	–	Sell	-14,820	Closed	-$680K	–	2240
2016 Q1	$680K	Sell	14,820 -52,814	-78%	-$2.56M	﹤0.01%	1896
2015 Q4	$4.17M	Buy	67,634 +50,064	+285%	+$3.52M	﹤0.01%	1417
2015 Q3	$978K	Hold	17,570	–	–	﹤0.01%	1831
2015 Q2	$1.07M	Buy	+17,570	New	+$1M	﹤0.01%	1826
2015 Q1	–	Sell	-129,745	Closed	-$7.48M	–	2285
2014 Q4	$7.48M	Buy	129,745 +335	+0.3%	+$14.1K	﹤0.01%	1326
2014 Q3	$3.69M	Buy	+129,410	New	+$3.2M	﹤0.01%	1521

Other funds holding KITE

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group's KITE Position: Q3 2017 in Review

Wellington Management Group sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 112,933 shares — an estimated $11.7M sold.

Wellington Management Group first reported a position in KITE in Q3 2014 and held it in 8 quarters. The position peaked at $11.7M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

Wellington Management Group reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
Wellington Management Group sold 112,933 Kite Pharma, Inc. shares in Q3 2017, an estimated $11.7M.
Wellington Management Group first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 8 quarters.
Wellington Management Group's Kite Pharma, Inc. position peaked at $11.7M in Q2 2017.
244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Wellington Management Group's 13F filing for Q3 2017, filed 13 Nov 2017.